Total Payments
$1,567
2024 Payments
$276.46
Companies
8
Transactions
49
Medicare Patients
429
Medicare Billing
$162,874
Payment Breakdown by Category
Food & Beverage$1,567 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,567 | 49 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Orexo US, Inc. | $531.81 | 8 | $0 (2018) |
| Gilead Sciences, Inc. | $253.87 | 16 | $0 (2023) |
| Indivior Inc. | $251.67 | 10 | $0 (2024) |
| Braeburn Inc. | $154.98 | 4 | $0 (2024) |
| USWM, LLC | $127.17 | 3 | $0 (2024) |
| BioDelivery Sciences International, Inc. | $119.28 | 1 | $0 (2017) |
| ABBVIE INC. | $106.83 | 6 | $0 (2024) |
| Alkermes, Inc. | $21.38 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $276.46 | 7 | Braeburn Inc. ($138.72) |
| 2023 | $162.39 | 9 | Gilead Sciences, Inc. ($52.63) |
| 2022 | $224.74 | 13 | Gilead Sciences, Inc. ($142.16) |
| 2020 | $44.38 | 3 | Indivior Inc. ($32.87) |
| 2019 | $106.40 | 6 | Indivior Inc. ($58.83) |
| 2018 | $177.27 | 2 | Orexo US, Inc. ($90.54) |
| 2017 | $575.35 | 9 | Orexo US, Inc. ($441.27) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/07/2024 | USWM, LLC | — | Food and Beverage | In-kind items and services | $84.83 | General |
| 06/11/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | Cash or cash equivalent | $96.58 | General |
| Category: Opioid Use Disorder | ||||||
| 05/14/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: OUD | ||||||
| 04/04/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: VIROLOGY | ||||||
| 02/29/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: Opioid Use Disorder | ||||||
| 01/26/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: VIROLOGY | ||||||
| 01/12/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Opioid Use Disorder | ||||||
| 11/20/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.06 | General |
| 10/31/2023 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: VIROLOGY | ||||||
| 10/24/2023 | USWM, LLC | ZIMHI (Drug), Lucemyra | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 10/24/2023 | USWM, LLC | ZIMHI (Drug), Lucemyra | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 09/12/2023 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Opioid Use Disorder | ||||||
| 07/13/2023 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: VIROLOGY | ||||||
| 03/10/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.86 | General |
| 03/10/2023 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: VIROLOGY | ||||||
| 01/18/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.71 | General |
| 12/14/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: VIROLOGY | ||||||
| 12/01/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $8.56 | General |
| 11/24/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.28 | General |
| 10/05/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $7.49 | General |
| 08/22/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.07 | General |
| 08/05/2022 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: OUD | ||||||
| 08/04/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $5.39 | General |
| 06/24/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $8.00 | General |
| 05/13/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $31.10 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 6 | 189 | 774 | $163,102 | $79,296 |
| 2020 | 8 | 240 | 738 | $157,344 | $83,578 |
Total Patients
429
Total Services
1,512
Medicare Billing
$162,874
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G2087 | Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month | Office | 2021 | 38 | 196 | $107,290 | $47,819 | 44.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 36 | 106 | $17,490 | $9,206 | 52.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 31 | 148 | $17,020 | $8,998 | 52.9% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 22 | 34 | $12,410 | $8,395 | 67.6% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2021 | 43 | 222 | $3,996 | $2,748 | 68.8% |
| 99484 | Care management services for behavioral health conditions, at least 20 minutes clinical staff time | Office | 2021 | 19 | 68 | $4,896 | $2,129 | 43.5% |
| G2087 | Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month | Office | 2020 | 33 | 132 | $66,480 | $34,491 | 51.9% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2020 | 29 | 71 | $25,915 | $17,531 | 67.6% |
| G2086 | Office-based treatment for opioid use disorder, including development of the treatment plan, care coordination, individual therapy and group therapy and counseling; at least 70 minutes in the first calendar month | Office | 2020 | 31 | 32 | $19,840 | $9,157 | 46.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 39 | 119 | $19,635 | $9,088 | 46.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 33 | 114 | $13,026 | $5,883 | 45.2% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2020 | 14 | 23 | $5,938 | $3,583 | 60.3% |
| 80305 | Testing for presence of drug | Office | 2020 | 40 | 209 | $3,774 | $2,629 | 69.7% |
| 99484 | Care management services for behavioral health conditions, at least 20 minutes clinical staff time | Office | 2020 | 21 | 38 | $2,736 | $1,216 | 44.4% |
About Dr. Robert Shearer, MD
Dr. Robert Shearer, MD is a Gynecology healthcare provider based in Springfield, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134142987.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Shearer, MD has received a total of $1,567 in payments from pharmaceutical and medical device companies, with $276.46 received in 2024. These payments were reported across 49 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,567).
As a Medicare-enrolled provider, Shearer has provided services to 429 Medicare beneficiaries, totaling 1,512 services with total Medicare billing of $162,874. Data is available for 2 years (2020–2021), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecology
- Other Specialties Addiction Medicine
- Location Springfield, TN
- Active Since 07/25/2006
- Last Updated 12/24/2024
- Taxonomy Code 207VG0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1134142987
Products in Payments
- Zubsolv (Drug) $531.81
- SUBLOCADE (Drug) $236.87
- BRIXADI (Drug) $154.98
- BELBUCA (Drug) $119.28
- MAVYRET (Drug) $106.83
- ZIMHI (Drug) $42.34
- VIVITROL (Drug) $21.38
- SUBOXONE SUBLINGUAL FILM (Drug) $14.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecology Doctors in Springfield
Dr. David Redfern, M.d, M.D
Gynecology — Payments: $48,015
Gynecology $48,015
Dr. Donald Kratz, M.d, M.D
Gynecology — Payments: $586.57
Gynecology $586.57
Howard Trietsch, Md, MD
Gynecology — Payments: $304.38
Gynecology $304.38
Donald Johnson, M.d, M.D
Gynecology — Payments: $105.50
Gynecology $105.50
Ernest Ertmoed, M.d, M.D
Gynecology — Payments: $22.53
Gynecology $22.53
William Schultz, M.d, M.D
Gynecology
Gynecology